Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Paclitaxel/Cisplatin/RT vs Irinotecan/Cisplatin/RT in Esophageal Adenocarcinoma
NCT00033657Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Aug 2002
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, irinotecan in esophageal adenocarcinoma (EAC), gastroesophageal junction adenocarcinoma, sponsored by Eastern Cooperative Oncology Group. Started Aug 2002; status: completed.
02
Drugs
paclitaxelirinotecan
03
Conditions
esophageal adenocarcinoma (EAC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT00033657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00033657.